Skip to main content
An official website of the United States government

Citing TARGET in Publications and Presentations

Therapeutically Applicable Research to Generate Effective Treatments (TARGET) requests that authors who use data from TARGET acknowledge the appropriate project team(s) in their work by referencing the TARGET dataset in accordance with the Data Use Certification posted at dbGaP. Investigators hoping to collaborate with TARGET members should contact the principal investigator of the disease project team.

We suggest the following language for citations:

"The results published here are in whole or part based upon data generated by the Therapeutically Applicable Research to Generate Effective Treatments ( initiative, phs000218. The data used for this analysis are available at the Genomic Data Commons (" 

Visit for guidance on citing the data at the Genomic Data Commons.

Disease dbGaP Sub-study ID
Acute Lymphoblastic Leukemia (ALL): Pilot Phase 1 phs000463
Acute Lymphoblastic Leukemia (ALL): Expansion Phase 2 phs000464
Acute Myeloid Leukemia (AML) phs000465
Cancer Model Systems (MDLS): Cell Lines and Xenografts, including Pediatric Preclinical Testing Program (PPTP) phs000469
Clear Cell Sarcoma of the Kidney (CCSK) phs000466
Neuroblastoma (NB) phs000467
Osteosarcoma (OS) phs000468
Rhabdoid Tumor (RT) phs000470
Wilms Tumor (WT) phs000471

Researchers who plan to prepare manuscripts containing descriptions of TARGET pediatric cancer data that would be of comparable scope to an initial TARGET disease-specific comprehensive, global analysis publication, and journal editors who receive such manuscripts, are strongly encouraged to coordinate their independent reports with TARGET’s publication schedule. Comparable scope is defined as global genome-wide analysis of TARGET disease-specific data from one or more platforms or an analysis of multiple TARGET diseases.

If you have questions, do not hesitate to contact

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Citing TARGET in Publications and Presentations was originally published by the National Cancer Institute.”